Top Markets
Coin of the day
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
株式のランク #39158
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
株価
$0.995
最終同期: 2023-07-07
時価総額
$624.98K
変化(1日)
-0.50%
変化(1年)
0.00%
US
取引 H-CYTE, Inc. (HCYT)

カテゴリー

H-CYTE, Inc.(HCYT)の配当利回りの履歴
H-CYTE, Inc.(銘柄コード: HCYT)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
H-CYTE, Inc.(HCYT)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)